adverse_event	pathway	size	p_value	adjusted_p_value
arrhythmia	inhibitory postsynaptic potential	12	4.4194089901697e-07	0.00131565805637352
arrhythmia	positive regulation of vasoconstriction	33	1.18102440270005e-05	0.0175795482341903
arrhythmia	regulation of synaptic vesicle exocytosis	57	5.05655639594758e-05	0.0423521345082275
arrhythmia	nervous system process	57	5.69057904040678e-05	0.0423521345082275
cardiac arrest	inhibitory postsynaptic potential	12	6.20473780897373e-07	0.00184715044573148
myoclonus	response to cocaine	35	1.15183850586275e-07	0.000342902323195341
myoclonus	adenylate cyclase-activating adrenergic receptor signaling pathway	20	2.78070242515587e-07	0.000413907555984451
myoclonus	positive regulation of phosphatidylinositol 3-kinase signaling	100	4.56129489857246e-07	0.000452632497101674
myoclonus	response to morphine	26	1.70719433932121e-06	0.00115048454911663
myoclonus	negative regulation of blood pressure	27	1.99901131428555e-06	0.00115048454911663
myoclonus	excitatory postsynaptic potential	65	2.31874615206577e-06	0.00115048454911663
myoclonus	negative regulation of synaptic transmission, glutamatergic	12	4.40793590974336e-06	0.00187463217190086
myoclonus	synaptic transmission, dopaminergic	12	6.04623107827835e-06	0.00224995374000433
myoclonus	positive regulation of cell growth	86	8.06593815115165e-06	0.00266803309733094
myoclonus	positive regulation of phospholipase C activity	13	1.0429434197114e-05	0.00310484256048083
myoclonus	positive regulation of renal sodium excretion	14	1.32416847885918e-05	0.00358368141960345
myoclonus	prepulse inhibition	15	1.65120323346304e-05	0.0040963600216829
myoclonus	regulation of synaptic vesicle exocytosis	57	2.47438545528036e-05	0.00566634269259203
myoclonus	cellular defense response	53	3.12230868613089e-05	0.00663936639900833
myoclonus	phosphatidylinositol-mediated signaling	58	3.61816724061734e-05	0.00715751291830154
myoclonus	negative regulation of adenylate cyclase activity	21	4.08725964431059e-05	0.00715751291830154
myoclonus	positive regulation of cardiac muscle hypertrophy	25	4.08725964431059e-05	0.00715751291830154
myoclonus	positive regulation of MAP kinase activity	75	5.45262152929129e-05	0.0090180301626112
myoclonus	positive regulation of long-term synaptic potentiation	25	6.30362534769168e-05	0.00980690014017801
myoclonus	vascular endothelial growth factor receptor signaling pathway	93	6.5884448372039e-05	0.00980690014017801
myoclonus	arachidonic acid secretion	25	7.18672033136702e-05	0.0100617362134971
myoclonus	circadian regulation of gene expression	85	7.43561292230218e-05	0.0100617362134971
myoclonus	positive regulation of reactive oxygen species metabolic process	28	0.000103107932896379	0.0133457528796748
myoclonus	adenylate cyclase-inhibiting dopamine receptor signaling pathway	13	0.000112892040742066	0.0137182224255723
myoclonus	positive regulation of mitotic nuclear division	36	0.000115201733503294	0.0137182224255723
myoclonus	ERBB2 signaling pathway	32	0.000156925063692227	0.01796791979276
myoclonus	regulation of circadian sleep/wake cycle, sleep	10	0.000168967151418958	0.0186301929546014
myoclonus	response to amphetamine	35	0.000189555306507437	0.0195241363591705
myoclonus	calcium-mediated signaling	97	0.000190191452608648	0.0195241363591705
myoclonus	positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	41	0.000207397179163718	0.0199998909417889
myoclonus	locomotory behavior	88	0.000208262216726724	0.0199998909417889
myoclonus	one-carbon metabolic process	41	0.00024626869323685	0.0229106843676907
myoclonus	phosphatidylinositol 3-kinase signaling	44	0.000267351159393983	0.0241183151974511
myoclonus	phospholipase C-activating dopamine receptor signaling pathway	10	0.000314025649061153	0.0267101244930015
myoclonus	regulation of establishment of endothelial barrier	10	0.000314025649061153	0.0267101244930015
myoclonus	bicarbonate transport	74	0.000390261006281165	0.0299831185975275
myoclonus	cAMP catabolic process	10	0.000402863535069231	0.0299831185975275
myoclonus	G protein-coupled adenosine receptor signaling pathway	10	0.000402863535069231	0.0299831185975275
myoclonus	positive regulation of T-helper 1 type immune response	15	0.000402863535069231	0.0299831185975275
myoclonus	regulation of feeding behavior	10	0.000402863535069231	0.0299831185975275
myoclonus	collagen catabolic process	65	0.000418518301294166	0.0303885117793349
myoclonus	negative regulation of voltage-gated calcium channel activity	12	0.000502477434859102	0.0353833961711027
myoclonus	negative regulation of protein kinase B signaling	57	0.000511080294040112	0.0353833961711027
myoclonus	inhibitory postsynaptic potential	12	0.000612795480143729	0.0414611850997246
myoclonus	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	53	0.000653551170611324	0.0432360407757758
myoclonus	behavioral response to cocaine	13	0.000733746152819275	0.0445788223865915
myoclonus	diet induced thermogenesis	12	0.000733746152819275	0.0445788223865915
myoclonus	embryonic morphogenesis	12	0.000733746152819275	0.0445788223865915
myoclonus	negative regulation of systemic arterial blood pressure	12	0.000733746152819275	0.0445788223865915
myoclonus	sensory perception of pain	57	0.000775492581751046	0.0461728283174573
myoclonus	G protein-coupled receptor internalization	18	0.000865258283477851	0.048601394526671
myoclonus	negative regulation of cytosolic calcium ion concentration	14	0.000865258283477851	0.048601394526671
myoclonus	positive regulation of synaptic transmission, GABAergic	13	0.000865258283477851	0.048601394526671
pseudomembranous colitis	response to amyloid-beta	17	1.70987449194802e-07	0.000509029636252925
pseudomembranous colitis	learning or memory	75	1.57078485118341e-05	0.0233811325098651
nephropathy	intracellular steroid hormone receptor signaling pathway	13	1.0144247096207e-06	0.00301994236054081
nephropathy	G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	66	6.69651068064832e-06	0.00996775614814502
rash erythematous	amyloid-beta clearance	26	1.67681893386977e-06	0.00499188996613029
rash erythematous	peptidyl-tyrosine autophosphorylation	44	3.20555279707875e-05	0.0477146533845172
rash macular	positive regulation of phosphatidylinositol 3-kinase signaling	100	2.09332870792978e-08	6.23183956350696e-05
rash macular	peptidyl-tyrosine autophosphorylation	44	8.58861719342084e-07	0.00127841566924069
rash macular	cellular response to fluid shear stress	12	1.75200199765811e-06	0.00173856998234273
rash macular	amyloid-beta clearance	26	2.89053793851424e-06	0.00215128286073922
rash macular	extracellular matrix disassembly	72	1.00546711434078e-05	0.00598655119878498
rash macular	response to tumor necrosis factor	31	3.15159828296795e-05	0.015637180147326
rash macular	positive regulation of nitric oxide biosynthetic process	44	7.00412375618177e-05	0.029787537745933
rash macular	hormone-mediated signaling pathway	52	0.000122868686074224	0.0422149499157879
rash macular	cellular response to cytokine stimulus	56	0.000176005242311667	0.0422149499157879
rash macular	dendritic spine maintenance	12	0.000184178355945085	0.0422149499157879
rash macular	positive regulation of programmed cell death	11	0.000184178355945085	0.0422149499157879
rash macular	glucose metabolic process	63	0.000196551574636107	0.0422149499157879
rash macular	endothelial cell differentiation	11	0.000224814463774878	0.0422149499157879
rash macular	regulation of neuroinflammatory response	12	0.000224814463774878	0.0422149499157879
rash macular	cellular response to growth factor stimulus	59	0.000242178424461971	0.0422149499157879
rash macular	response to glucocorticoid	60	0.000254563434019985	0.0422149499157879
rash macular	positive regulation of ceramide biosynthetic process	12	0.000269426956130322	0.0422149499157879
rash macular	positive regulation of podosome assembly	12	0.000269426956130322	0.0422149499157879
rash macular	transcytosis	13	0.000269426956130322	0.0422149499157879
rash macular	replicative senescence	13	0.000318000154082267	0.0473343229351454
coagulopathy	G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	66	4.72927009025817e-13	1.40790370586986e-09
coagulopathy	phospholipase C-activating G protein-coupled receptor signaling pathway	65	3.79957467001407e-08	5.65566689631595e-05
coagulopathy	sensory perception of pain	57	6.89969838097802e-07	0.000684680069339053
coagulopathy	positive regulation of vasoconstriction	33	2.69837458852059e-06	0.00200826528750645
coagulopathy	replicative senescence	13	8.49337161736168e-06	0.00505695346097715
coagulopathy	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	69	3.90515689820255e-05	0.019376086809915
coagulopathy	extracellular matrix disassembly	72	5.69069067099181e-05	0.0211764826594283
coagulopathy	regulation of blood pressure	73	5.69069067099181e-05	0.0211764826594283
coagulopathy	G protein-coupled serotonin receptor signaling pathway	25	6.64791798797993e-05	0.0219898353891292
coagulopathy	regulation of sensory perception of pain	32	0.000104667295523018	0.0311594538772026
coagulopathy	positive regulation of cell growth	86	0.000126803147334286	0.0323164928896718
coagulopathy	DNA damage checkpoint	40	0.000141120056286776	0.0323164928896718
coagulopathy	regulation of postsynaptic membrane potential	32	0.000141120056286776	0.0323164928896718
coagulopathy	activation of phospholipase C activity	36	0.000169489288123378	0.036040686481664
respiratory acidosis	positive regulation of blood coagulation	16	4.91109213079065e-06	0.0146203212733638
respiratory acidosis	protein processing	79	1.05162057124977e-05	0.0156533722030529
respiratory acidosis	extracellular matrix disassembly	72	2.0271090282718e-05	0.0201156785905505
respiratory acidosis	adipose tissue development	31	5.32966987448967e-05	0.025051937320273
respiratory acidosis	positive regulation of phosphatidylinositol 3-kinase signaling	100	5.76371286204227e-05	0.025051937320273
respiratory acidosis	ERBB2 signaling pathway	32	5.89061341088044e-05	0.025051937320273
respiratory acidosis	positive regulation of vasoconstriction	33	5.89061341088044e-05	0.025051937320273
prostate cancer	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	69	4.1923805200939e-06	0.0124807168083195
